Patients, Disease characteristics, and treatment schedule
DISEASE CHARACTERISTIC, AML
10 patients with relapsed/refractory AML were included in this trial, and their disease characteristics are demonstrated in Table 
Patient demographics and baseline characteristics and engraftment patients feature*Receptor-ligand model